Decheng Capital

Decheng Capital

SECTOR:

Medtech, HC Services, Therapeutics, HCIT, Diagnostics, Others

FUND/VEHICLE:

NFLS Fund & Core Investment

INVESTMENT DATE:

2012

GEOGRAPHY:

China, US

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

Decheng Capital is a leading investment firm that provides capital and strategic support to early stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. We are a group of dedicated professionals with complementary expertise who have outstanding track records of building highly successful companies globally. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital under management and support from some of the most prestigious LPs in the world, Decheng is poised to deliver superior returns for our investors and create value for our entrepreneur partners.